Memantina Noridem

Memantine Hydrochloride, the active ingredient in Memantina Noridem, is an NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of moderate to severe Alzheimer’s disease in adults. GNH USA supplies Memantina Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine Hydrochloride is used in the management of neurodegenerative conditions that involve glutamatergic excitotoxicity. - Alzheimer’s disease (moderate to severe): helps improve cognition, daily functioning and may slow disease progression.

Memantina Noridem may cause a range of adverse reactions.

Common Side Effects: - Dizziness: transient light‑headedness, especially after dose initiation. - Headache: mild to moderate intensity, often resolves with continued therapy. - Constipation: reduced bowel movements, manageable with diet or laxatives. - Fatigue: feeling unusually tired or low energy. - Nausea: mild stomach upset, may improve over time.

Serious or Rare Side Effects: - Seizures: rare occurrence, requires immediate medical attention. - Hallucinations or psychosis: visual or auditory disturbances, may need dose adjustment. - Severe hypertension: sudden increase in blood pressure, monitor regularly. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Liver enzyme elevation: abnormal liver function tests, monitor in hepatic impairment. - Suicidal thoughts: rare but serious, assess mental health regularly.

When prescribing Memantina Noridem, clinicians should consider several safety aspects. - Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Elderly patients: start at low dose and titrate slowly to minimize CNS effects. - Psychiatric history: observe for emergence or worsening of hallucinations or agitation. - Pregnancy: safety not established; use only if potential benefit justifies risk. - Breastfeeding: unknown excretion in milk; weigh benefits against potential infant exposure. - Store at ambient temperature: keep below 25 °C, retain in original container, protect from moisture and direct sunlight.

Memantina Noridem can interact with other medicines that affect the central nervous system or NMDA pathways.

Major Interactions (Avoid): - Amantadine: combined use may increase risk of confusion, dizziness, and seizures. - Ketamine: additive NMDA antagonism can lead to profound CNS depression.

Moderate Interactions (Monitor Closely): - Dextromethorphan: may enhance CNS side effects such as dizziness and hallucinations. - Anticholinergic agents: can exacerbate cognitive impairment. - High‑dose vitamin D: may increase serum calcium, potentially affecting neuronal excitability. - Antihypertensive drugs: monitor blood pressure as memantine can cause hypertension. - Other NMDA antagonists: assess cumulative effect on glutamate signaling.